Extrafine combination beclomethasone dipropionate/ formoterol therapy in obstructive lung diseases
Bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) are chronic inflammatory diseases of the airways. Inhaled bronchodilators and corticosteroids are the cornerstone of pharmacological long-term treatment for asthma and COPD. The efficacy of any topical inhaled medication is depen...
Main Authors: | I. N. Trofimenko, B. A. Chernyak |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-08-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5759 |
Similar Items
-
Pulmonary Delivery of Curcumin and Beclomethasone Dipropionate in a Multicomponent Nanosuspension for the Treatment of Bronchial Asthma
by: Luca Casula, et al.
Published: (2021-08-01) -
Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
by: Roberto W. Dal Negro, et al.
Published: (2018-06-01) -
Construction of Lipid–Drug Conjugates for Beclomethasone Dipropionate
by: Shishuai Dang, et al.
Published: (2022-11-01) -
Bronchial asthma: simple solutions of complex issues
by: I. V. Leshchenko, et al.
Published: (2019-04-01) -
Instant Formulation of Inhalable Beclomethasone Dipropionate—Gamma-Cyclodextrin Composite Particles Produced Using Supercritical Assisted Atomization
by: Hsien-Tsung Wu, et al.
Published: (2023-06-01)